EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating Molecular Dynamics, Molecular Docking, and Machine Learning for Predicting SARS-CoV-2 Papain-like Protease Binders

Ann Varghese, Jie Liu, Tucker A Patterson, Huixiao Hong iD

Molecules · 2025

DOI: 10.3390/molecules30142985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Ann Varghese und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Machine Learning, Molecular Dynamics Simulation, SARS-CoV-2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Food and Drug Administration (FDA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID-19) produced devastating health and economic impacts worldwide. While progress has been made in vaccine development, effective antiviral treatments remain limited, particularly those targeting the papain-like protease (PLpro) of SARS-CoV-2. PLpro plays a key role in viral replication and immune evasion, making it an attractive yet underexplored target for drug repurposing. In this study, we combined machine learning, molecular dynamics, and molecular docking to identify potential PLpro inhibitors in existing drugs. We performed long-timescale molecular dynamics simulations on PLpro–ligand complexes at two known binding sites, followed by structural clustering to capture representative structures. These were used for molecular docking, including a training set of 127 compounds and a library of 1107 FDA-approved drugs. A random forest model, trained on the docking scores of the representative conformations, yielded 76.4% accuracy via leave-one-out cross-validation. Applying the model to the drug library and filtering results based on prediction confidence and the applicability domain, we identified five drugs as promising candidates for repurposing for COVID-19 treatment. Our findings demonstrate the power of integrating computational modeling with machine learning to accelerate drug repurposing against emerging viral targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationMachine LearningMolecular Dynamics SimulationSARS-CoV-2Coronavirus Papain-Like ProteasesAntiviral AgentsProtease InhibitorsDrug RepositioningHumansCOVID-19 Drug TreatmentBinding SitesProtein BindingCOVID-19Ligands

Stichwörter der Autor:innen

SARS-CoV-2drug repurposingmachine learningmolecular dockingmolecular dynamicspapain-like protease

Substanzen

Coronavirus Papain-Like ProteasesAntiviral AgentsProtease Inhibitorspapain-like protease, SARS-CoV-2Ligands

Autor:innen und Institutionen

  • National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.

ORCID-Profile: Huixiao Hong

Förderung

  • U.S. Food and Drug Administration (FDA)

Zitieren

APA

Varghese, A., Liu, J., Patterson, T. A., & Hong, H. (2025). Integrating Molecular Dynamics, Molecular Docking, and Machine Learning for Predicting SARS-CoV-2 Papain-like Protease Binders. Molecules. https://doi.org/10.3390/molecules30142985

Vancouver

Varghese A, Liu J, Patterson TA, Hong H. Integrating Molecular Dynamics, Molecular Docking, and Machine Learning for Predicting SARS-CoV-2 Papain-like Protease Binders. Molecules. 2025. doi:10.3390/molecules30142985

BibTeX
@article{Varghese2025,
  author = {Varghese, Ann and Liu, Jie and Patterson, Tucker A and Hong, Huixiao},
  title = {Integrating Molecular Dynamics, Molecular Docking, and Machine Learning for Predicting SARS-CoV-2 Papain-like Protease Binders},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30142985}
}
Kostenlos starten →